Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
Add more filters










Database
Language
Publication year range
1.
Int J Pharm ; 614: 121456, 2022 Feb 25.
Article in English | MEDLINE | ID: mdl-35017024

ABSTRACT

The FDA-approved anthelmintic flubendazole has shown potential to be repositioned to treat cancer and dry macular degeneration; however, its poor water solubility limits its use. Amorphous solid dispersions may overcome this challenge, but the balance of excipients may impact the preparation method and drug release. The purpose of this study was to evaluate the influence of adjuvants and drug loading on the development of an amorphous solid dispersion of flubendazole-copovidone by hot-melt extrusion. The drug, copovidone, and adjuvants (magnesium stearate and hydroxypropyl cellulose) mixtures were statistically designed, and the process was performed in a twin-screw extruder. The study showed that flubendazole and copovidone mixtures were highly extrudable, except when drug loading was high (>40%). Furthermore, magnesium stearate positively impacted the extrusion and was more effective than hydroxypropyl cellulose. The extruded materials were evaluated by modulated differential scanning calorimetry and X-ray powder diffraction, obtaining positive amorphization and physical stability results. Pair distribution function analysis indicated the presence of drug-rich domains with medium-range order structure and no evidence of polymer-drug interaction. All extrudates presented faster dissolution (HCl, pH 1.2) than pure flubendazole, and both adjuvants had a notable influence on the dissolution rate. In conclusion, hot-melt extrusion may be a viable option to obtain stable flubendazole:copovidone amorphous dispersions.


Subject(s)
Chemistry, Pharmaceutical , Excipients , Calorimetry, Differential Scanning , Drug Carriers , Drug Compounding , Hot Temperature , Mebendazole/analogs & derivatives , Pyrrolidines , Solubility , Vinyl Compounds
2.
Int J Pharm ; 602: 120611, 2021 Jun 01.
Article in English | MEDLINE | ID: mdl-33872710

ABSTRACT

The levitation of samples in an acoustic field has been of interest in the preparation and study of amorphous solid dispersions (ASD). Here, niclosamide-polymer solutions were levitated in a multi-emitter single-axis acoustic levitator and analyzed for 10 min at a High-resolution synchrotron X-ray powder diffraction beamline. This assembly enabled high-quality and fast time-resolved measurements with microliter sample size and measurement of solvent evaporation and recrystallization of niclosamide (NCL). Polymers HPMCP-55S, HPMCP-50, HPMCP-55, Klucel®, and poloxamers were not able to form amorphous dispersions with NCL. Plasdone® and Soluplus® demonstrated excellent properties to form NCL amorphous dispersions, with the last showing superior solubility enhancement. Furthermore, this fast levitation polymer screening showed good agreement with results obtained by conventional solvent evaporation screening evaluated for five days in a stability study, carried out at 40 °C/75% RH. The study showed that acoustic levitation and high-resolution synchrotron combination opens up a new horizon with great potential for accelerating ASD formulation screening and analysis.


Subject(s)
Niclosamide , Synchrotrons , Acoustics , Chemistry, Pharmaceutical , Powders , Solubility , X-Ray Diffraction , X-Rays
3.
Int J Pharm ; 600: 120500, 2021 May 01.
Article in English | MEDLINE | ID: mdl-33753163

ABSTRACT

We use X-ray pair distribution function (PDF) analysis applied to high-energy synchrotron X-ray powder diffraction data to evaluate the amorphous solid dispersions interactions and their aging stability. The obtained systems are based on hydroxypropyl methylcellulose (hypromellose) derivatives and flubendazole (FBZ) drug dispersions prepared using a spray-dryer technique. We carry out stability studies under aging parameters (40 °C/75% relative humidity) to tune the systems' recrystallization. The results reveal that ion-base interactions between the drug-polymer matrix are responsible for reducing clustering processes yielding slower recrystallization and different ordering in the hypromellose phthalate (HPMCP/FBZ) and hypromellose acetate succinate (HPMC-AS/FBZ) systems and complete drug clustering in hypromellose (HPMC-E3/FBZ). The structural ordering was accessed using differential X-ray PDFs that revealed the region between 3.5 Å and 5.0 Å could be related to FBZ intermolecular interactions and is more ordered for the least stable system (HPMC-E3/FBZ) and less ordered for the most stable system (HPMCP/FBZ). These results show that the ion-base interactions between drug and matrix occur at these intermolecular distances.


Subject(s)
Mebendazole , Methylcellulose , Drug Stability , Hypromellose Derivatives , Mebendazole/analogs & derivatives , Polymers , Solubility
4.
Luminescence ; 33(7): 1281-1287, 2018 Nov.
Article in English | MEDLINE | ID: mdl-30252200

ABSTRACT

Monoclinic bismuth oxide (α-Bi2 O3 ) has attractive optical properties and, therefore, its photoluminescence (PL) behavior has been increasingly explored. Besides this fact, the influence of synthesis methods on PL properties of α-Bi2 O3 still requires research. This paper describes the influence of precipitation (PPT) and microwave-assisted hydrothermal (MAH) methods on PL properties of acicular α-Bi2 O3 microcrystals. The synthesis method promoted structural modifications on α-Bi2 O3 , in particular PPT increased the density of oxygen vacancies significantly. As a result, the PL properties of samples were different depending on the method of synthesis. PPT samples presented their maximum PL emission at 1.91 eV (red), while MAH samples had their maximum at 2.61 eV (blue). These results indicate the possibility of controlling PL properties of α-Bi2 O3 by simply choosing the adequate synthesis method.


Subject(s)
Bismuth/chemistry , Chemistry Techniques, Synthetic/methods , Fluorescent Dyes/chemical synthesis , Chemistry Techniques, Synthetic/instrumentation , Color , Fluorescent Dyes/chemistry , Luminescence , Microwaves , Needles
5.
J Pharm Sci ; 103(11): 3567-3575, 2014 Nov.
Article in English | MEDLINE | ID: mdl-25197019

ABSTRACT

Finasteride (FNT) is a drug that inhibits human enzyme type II 5α-reductase that metabolizes testosterone into dihydrotestosterone. There are two enantiotropic polymorphs with known crystal structure: designated as forms I and II. Identification and control of these polymorphic forms in mixtures can be performed using X-ray powder diffraction (XRPD) data and Rietveld method (RM). As experimental conditions may limit the detection of minority phases in mixtures, it is interesting to show what are these limits for some usual and one high-resolution equipment. So, in this work, we discuss the parameters to find the limit of the detection in binary mixtures of forms I and II of FNT according to each experimental condition. The samples analyzed were binary mixtures prepared with anhydrous polymorphs of the drug FNT. These samples were measured in four diffractometers with different experimental condition. These equipments represent the main resolutions generally used for drug analysis by XRPD. For the development of this work, a batch of form I was obtained pure, and another batch with forms I and II was used to obtain pure form II by heat treatment. Depending on the experimental condition, the polymorphs could be detected in a proportion as low as 0.5 wt%. © 2014 Wiley Periodicals, Inc. and the American Pharmacists Association J Pharm Sci 103:3567-3575, 2014.


Subject(s)
Crystallography, X-Ray , Finasteride/chemistry , Powder Diffraction , Technology, Pharmaceutical/methods , 5-alpha Reductase Inhibitors/chemistry , Crystallization , Crystallography, X-Ray/instrumentation , Equipment Design , Limit of Detection , Molecular Structure , Powder Diffraction/instrumentation , Technology, Pharmaceutical/instrumentation
SELECTION OF CITATIONS
SEARCH DETAIL